@article{article_1001948, title={A case report: Successful management of pulmonary aspergillosis associated with COVID ‐ 19 ARDS}, journal={Deneysel ve Klinik Tıp Dergisi}, volume={39}, pages={563–565}, year={2022}, author={Ergül, Dursun Fırat and Boran, Maruf}, keywords={covid 19, ARDS, Pulmuner Aspergilloz Basarılı Weaning, Steroid Tedavisi}, abstract={The recent global outbreak of coronavirus disease-19, also known as COVID-19, has infected more than 142 million people worldwide, causing more than 3 million deaths. It has been shown that up to 40% of hospitalized COVID-19 patients may develop ARDS. Although not proven, anti-inflammatory and anti-cytokine treatments are recommended to suppress the cytokine storm that develops in the early stages of the disease.
In this case report, a case of pulmonary aspergillus developed as a complication of treatment for ARDS caused by covid 19 in a 50-year-old male patient will be presented in the light of current literature.}, number={2}, publisher={Ondokuz Mayıs University}